The FDA has accepted a new drug application for the glioma-imaging agent Pixclara, with a decision expected next year.

The FDA accepted the new drug application for TLX101-CDx and granted priority review to the agent in glioma. The FDA has ...

For the treatment of glioblastoma, immunotherapy represents a promising, though complex, avenue. Due to the tumour’s highly ...

While gliomas usually grow in the brain they can also form in the spinal cord. They are also difficult to reach and treat ...

Researchers Develop Promising Therapy Treatment That Can Kill Glioblastoma Cells in Newly ... and a prevalent type, known as a glioma, has a poor five-year survival rate. In a new study ...

A pioneering research study announced today (October 23) will trial multiple new treatments for people in the UK living with ...

The main progress will probably come from integrated high-throughput studies of the glioma genome ... proposed a molecular classification of glioblastoma in several subtypes: this will also ...

Glioblastomas are the most common type of cancerous brain tumor in adults ... to fund the “next-Generation aGile Genomically Guided Glioma platform trial”, also known as the 5G platform ...

Glioblastoma is the most common and deadliest form of brain cancer. Patients face a bleak prognosis - the average survival after diagnosis is ...